Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008486232> ?p ?o ?g. }
- W3008486232 endingPage "162" @default.
- W3008486232 startingPage "145" @default.
- W3008486232 abstract "Neoadjuvant chemotherapy is beneficial against breast cancer, but its toxicity causes painful chemotherapy-induced neuropathy which decreases seriously patients’ quality of life. Development of effective therapy is crucial because current treatments are unsatisfactory. While animal models have previously been produced to test therapeutics against chemotherapy-induced neuropathy, neuropathic pain evoked by the frequently used neoadjuvant-chemotherapy involving sequentially epirubicin and docetaxel has never been modeled. Duloxetine, a serotonin/noradrenalin-reuptake inhibitor, is recommended against chemotherapy-induced neuropathy, but duloxetine exhibits controversial and adverse effects requiring its discontinuation. Here, we firstly produced and characterized a rat model for epirubicin-docetaxel induced painful neuropathy by using behavioral methods including the von Frey filament and the acetone tests that were combined with electrophysiological assessment of peripheral nerve functions and immunohistological analyzes. Using this model, we investigated the possibility to improve duloxetine efficacy and safety by combining its low doses (2 mg/kg/2 days) with the potent neuroprotector allopregnanolone (4 mg/kg/2 days). This concomitant therapy was more effective than separate duloxetine or allopregnanolone treatment to prevent epirubicin-docetaxel induced cold allodynia, mechanical allodynia/hyperalgesia, peripheral nerve functional/electrophysiological, and histological alterations. Interestingly, duloxetine-allopregnanolone concomitant treatment (but not duloxetine) also prevented epirubicin-docetaxel induced Schwann cell dedifferentiation and related macrophage (CD11b/c-positive cells) infiltration in sciatic nerves. Altogether, our results suggest that duloxetine and allopregnanolone concomitant treatment may represent a promising therapeutic option to counteract efficiently painful neuropathy or epirubicin-docetaxel evoked peripheral nerve tissue damages and dysfunctions." @default.
- W3008486232 created "2020-03-06" @default.
- W3008486232 creator A5008371415 @default.
- W3008486232 creator A5023780227 @default.
- W3008486232 creator A5066476038 @default.
- W3008486232 creator A5078364964 @default.
- W3008486232 date "2020-02-27" @default.
- W3008486232 modified "2023-10-18" @default.
- W3008486232 title "Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy–Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment" @default.
- W3008486232 cites W1544192225 @default.
- W3008486232 cites W1873305365 @default.
- W3008486232 cites W1882623085 @default.
- W3008486232 cites W1913690131 @default.
- W3008486232 cites W1939084108 @default.
- W3008486232 cites W1949425569 @default.
- W3008486232 cites W1967076728 @default.
- W3008486232 cites W1969414426 @default.
- W3008486232 cites W1974542461 @default.
- W3008486232 cites W1981229614 @default.
- W3008486232 cites W1982140857 @default.
- W3008486232 cites W1984689348 @default.
- W3008486232 cites W1985208991 @default.
- W3008486232 cites W1991454881 @default.
- W3008486232 cites W1992879638 @default.
- W3008486232 cites W1997932302 @default.
- W3008486232 cites W2001116945 @default.
- W3008486232 cites W2002211622 @default.
- W3008486232 cites W2007302872 @default.
- W3008486232 cites W2011033166 @default.
- W3008486232 cites W2011533010 @default.
- W3008486232 cites W2011646109 @default.
- W3008486232 cites W2020833122 @default.
- W3008486232 cites W2029419388 @default.
- W3008486232 cites W2031380202 @default.
- W3008486232 cites W2036294483 @default.
- W3008486232 cites W2041389665 @default.
- W3008486232 cites W2043769299 @default.
- W3008486232 cites W2051636266 @default.
- W3008486232 cites W2053767639 @default.
- W3008486232 cites W2053782164 @default.
- W3008486232 cites W2057662279 @default.
- W3008486232 cites W2061107749 @default.
- W3008486232 cites W2062071281 @default.
- W3008486232 cites W2067087807 @default.
- W3008486232 cites W2067212451 @default.
- W3008486232 cites W2068888634 @default.
- W3008486232 cites W2073639884 @default.
- W3008486232 cites W2084092457 @default.
- W3008486232 cites W2084983915 @default.
- W3008486232 cites W2087354258 @default.
- W3008486232 cites W2089478011 @default.
- W3008486232 cites W2092322285 @default.
- W3008486232 cites W2096107960 @default.
- W3008486232 cites W2109846148 @default.
- W3008486232 cites W2114458368 @default.
- W3008486232 cites W2115574860 @default.
- W3008486232 cites W2127456696 @default.
- W3008486232 cites W2128412489 @default.
- W3008486232 cites W2128935757 @default.
- W3008486232 cites W2134545893 @default.
- W3008486232 cites W2135800076 @default.
- W3008486232 cites W2140441724 @default.
- W3008486232 cites W2143341124 @default.
- W3008486232 cites W2147597595 @default.
- W3008486232 cites W2149603226 @default.
- W3008486232 cites W2154980665 @default.
- W3008486232 cites W2156394189 @default.
- W3008486232 cites W2158473710 @default.
- W3008486232 cites W2164256326 @default.
- W3008486232 cites W2164361217 @default.
- W3008486232 cites W2164438100 @default.
- W3008486232 cites W2164774797 @default.
- W3008486232 cites W2170259378 @default.
- W3008486232 cites W2204696794 @default.
- W3008486232 cites W2217472701 @default.
- W3008486232 cites W2294088168 @default.
- W3008486232 cites W2396814975 @default.
- W3008486232 cites W2417006359 @default.
- W3008486232 cites W2537649884 @default.
- W3008486232 cites W2561701725 @default.
- W3008486232 cites W2564026052 @default.
- W3008486232 cites W2573195065 @default.
- W3008486232 cites W2580584788 @default.
- W3008486232 cites W2615255960 @default.
- W3008486232 cites W2620036274 @default.
- W3008486232 cites W2742958675 @default.
- W3008486232 cites W2744965085 @default.
- W3008486232 cites W2768454515 @default.
- W3008486232 cites W2769989400 @default.
- W3008486232 cites W2779907557 @default.
- W3008486232 cites W2806056063 @default.
- W3008486232 cites W2891826632 @default.
- W3008486232 cites W2939152062 @default.
- W3008486232 cites W2955647323 @default.
- W3008486232 cites W2972005567 @default.
- W3008486232 cites W568629826 @default.
- W3008486232 cites W99348004 @default.
- W3008486232 doi "https://doi.org/10.1007/s12640-020-00176-2" @default.